Efficacy and Safety of Dictyophora indusiata Fisch, Psilocybe cubensis (Earle) Sing. and Sesame oil compare with 0.1% Triamcinolone lotion in treating Psoriasis Patients: Open label , Randomized controlled trial.
Phase 2
- Conditions
- Psoriasis,a chronic skin cause by multifactorial factors such as immune activation,genetic and environment result in increased epidermal proliferation and inflammation. A wide range of treatments arExperimental,Open label ,randomized control trial,Efficacy and Safety ,treating,Psoriasis Patients,Herbal Recipe
- Registration Number
- TCTR20180125004
- Lead Sponsor
- n/a
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Psoriasis patient aged over 18 years, Lesion were distributed equally on both side of body They were signing the consent forms.
Exclusion Criteria
severe psoriasis ,Patients who are participating other ongoing project and required to continue study medication,
Pregnant or in lactation or planning to become pregnant. , No allergy to herb medicine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy and safety week 4,8,12 Modified Psoriasis Area and Severity Index (Modified PASI) and Physician global assessment (PGA)
- Secondary Outcome Measures
Name Time Method Satisfaction study week 12 Dermatology Life Quality Index (DLQI) and Visual Analog Scale (VAS)